Topotecan Completed Phase 2 Trials for Myelodysplastic Syndromes (MDS) / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003675Topotecan in Treating Patients With Myelodysplastic Syndrome